Biotech Showcase 2026

Biotech Showcase 2026 is a premier investor conference tailored for private and micro-mid-cap biotech companies. The event facilitates over 6,000 one-on-one meetings through partneringONE™, creating valuable opportunities for strategic collaboration and funding. More than 350 biotech companies will present their innovations across two specialized tracks: the TechBio Showcase and the Seed Showcase. Attendees can also engage in thought-provoking panels focused on biotech innovation and investment trends. The conference draws a global audience of over 3,200 biopharma leaders, including 1,200 investors, along with biotech executives, researchers, and strategic partners. 

Join us for an engaging fireside chat on Tuesday, January 13, from 3:30–3:50p.m. in the Imperial Ballroom, featuring Jim Anthony, Chief Commercial Officer and President, Parexel Biotech, and Vivek Mittal, Partner and Managing Director, Health Advances. The session, titled “Accelerating Clinical Development: Strategic Levers for Biotechs,” will explore how biotechs can thrive in an environment defined by finite funding horizons and milestone-driven value inflection points. Speed is survival—but accelerating development requires more than operational efficiency. Discover strategic approaches to de-risk development without compromising scientific or regulatory integrity, gain insights into trends shaping the clinical landscape over the next 3–5 years, and learn current strategies small and mid-sized biopharma are using to compress timelines, based on Parexel’s latest research. Don’t miss this opportunity to hear from industry leaders and elevate your development strategy.